David Oupický

10.9k total citations · 1 hit paper
195 papers, 8.9k citations indexed

About

David Oupický is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, David Oupický has authored 195 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Molecular Biology, 34 papers in Biomaterials and 34 papers in Biomedical Engineering. Recurrent topics in David Oupický's work include RNA Interference and Gene Delivery (110 papers), Advanced biosensing and bioanalysis techniques (77 papers) and Nanoparticle-Based Drug Delivery (30 papers). David Oupický is often cited by papers focused on RNA Interference and Gene Delivery (110 papers), Advanced biosensing and bioanalysis techniques (77 papers) and Nanoparticle-Based Drug Delivery (30 papers). David Oupický collaborates with scholars based in United States, China and Czechia. David Oupický's co-authors include Leonard W. Seymour, Karel Ulbrich, Ye‐Zi You, Devika S. Manickam, Ying Xie, Philip R. Dash, Minjie Sun, Čestmı́r Koňák, Jing Li and Yazhe Wang and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Advanced Materials.

In The Last Decade

David Oupický

194 papers receiving 8.8k citations

Hit Papers

Tumor-Penetrating Nanopar... 2017 2026 2020 2023 2017 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Oupický 5.1k 2.2k 2.2k 1.3k 1.1k 195 8.9k
Vladimír Šubr 2.7k 0.5× 3.3k 1.5× 2.6k 1.2× 730 0.6× 1.2k 1.1× 129 7.4k
J. Andrew MacKay 3.1k 0.6× 2.5k 1.1× 1.5k 0.7× 1.2k 0.9× 734 0.7× 98 6.6k
Gaurav Sahay 5.7k 1.1× 2.1k 0.9× 1.8k 0.8× 784 0.6× 455 0.4× 69 8.4k
A. Christy Hunter 4.3k 0.8× 4.3k 1.9× 2.9k 1.3× 623 0.5× 648 0.6× 90 9.6k
Lichen Yin 5.3k 1.0× 4.5k 2.0× 3.5k 1.6× 518 0.4× 1.9k 1.8× 195 11.6k
Guping Tang 3.3k 0.6× 2.5k 1.1× 2.2k 1.0× 716 0.6× 1.6k 1.4× 202 7.8k
Hidetaka Akita 7.6k 1.5× 2.5k 1.1× 1.7k 0.8× 1.7k 1.3× 423 0.4× 245 11.1k
Afsaneh Lavasanifar 4.3k 0.8× 4.6k 2.1× 2.1k 1.0× 363 0.3× 2.3k 2.1× 189 10.2k
Snow Stolnik 3.1k 0.6× 2.9k 1.3× 1.6k 0.7× 442 0.3× 1.2k 1.1× 131 7.6k
Dominik Witzigmann 6.2k 1.2× 2.3k 1.1× 2.0k 0.9× 754 0.6× 427 0.4× 64 9.1k

Countries citing papers authored by David Oupický

Since Specialization
Citations

This map shows the geographic impact of David Oupický's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Oupický with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Oupický more than expected).

Fields of papers citing papers by David Oupický

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Oupický. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Oupický. The network helps show where David Oupický may publish in the future.

Co-authorship network of co-authors of David Oupický

This figure shows the co-authorship network connecting the top 25 collaborators of David Oupický. A scholar is included among the top collaborators of David Oupický based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Oupický. David Oupický is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oupický, David, et al.. (2025). Strategies to overcome antibiotic resistance: silver nanoparticles and vancomycin in pathogen eradication. 2(3). 455–479. 11 indexed citations
2.
Islam, Farhana, Srijanee Das, Md Ashaduzzaman, et al.. (2024). Development of an extended action fostemsavir lipid nanoparticle. Communications Biology. 7(1). 917–917. 3 indexed citations
3.
Jia, Huizhen, Ling Ding, Ao Yu, et al.. (2022). A boronate-based modular assembly nanosystem to block the undesirable crosstalk between hepatic stellate cells and Kupffer cells. Bioactive Materials. 25. 569–579. 8 indexed citations
4.
Sil, Diptesh, Sudipta Panja, Raj Kumar, et al.. (2022). Self-Assembled Alkylated Polyamine Analogs as Supramolecular Anticancer Agents. Molecules. 27(8). 2441–2441. 2 indexed citations
5.
Panja, Sudipta, et al.. (2022). Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases. Advanced Healthcare Materials. 12(7). e2202400–e2202400. 18 indexed citations
6.
Tang, Weimin, Sudipta Panja, Siyuan Tang, et al.. (2022). Modified chitosan for effective renal delivery of siRNA to treat acute kidney injury. Biomaterials. 285. 121562–121562. 54 indexed citations
7.
Li, Zhaoting, Yixin Wang, Yuexin Shen, et al.. (2020). Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy. Science Advances. 6(20). eaaz9240–eaaz9240. 144 indexed citations
8.
Wu, Pengkai, Xinping Luo, Hui Wu, et al.. (2020). Combined Hydrophobization of Polyethylenimine with Cholesterol and Perfluorobutyrate Improves siRNA Delivery. Bioconjugate Chemistry. 31(3). 698–707. 27 indexed citations
9.
Wang, Yazhe, Ying Xie, Kameron V. Kilchrist, et al.. (2020). Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy. ACS Applied Materials & Interfaces. 12(4). 4308–4322. 136 indexed citations
10.
Yu, Fei, et al.. (2019). Synthesis and biological characterization of clicked chloroquine copolymers as macromolecular inhibitors of cancer cell migration. Journal of Polymer Science Part A Polymer Chemistry. 57(22). 2235–2242. 8 indexed citations
11.
Li, Zhaoting, Yuexin Shen, Yixin Wang, et al.. (2019). Perfluorocarbon Nanoemulsions for Combined Pulmonary siRNA Treatment of Lung Metastatic Osteosarcoma. Advanced Therapeutics. 2(7). 14 indexed citations
12.
Zhou, Zhanwei, Minghua Zhang, Yadong Liu, et al.. (2018). Reversible Covalent Cross-Linked Polycations with Enhanced Stability and ATP-Responsive Behavior for Improved siRNA Delivery. Biomacromolecules. 19(9). 3776–3787. 35 indexed citations
13.
Zhou, Yiwen, Fei Yu, Feiran Zhang, et al.. (2018). Cyclam-Modified PEI for Combined VEGF siRNA Silencing and CXCR4 Inhibition To Treat Metastatic Breast Cancer. Biomacromolecules. 19(2). 392–401. 35 indexed citations
14.
Li, Huipeng, Xue Yang, Fang Gao, et al.. (2018). Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy. Journal of Controlled Release. 292. 78–90. 41 indexed citations
15.
Chen, Gang, Kaikai Wang, Qi Hu, et al.. (2017). Combining Fluorination and Bioreducibility for Improved siRNA Polyplex Delivery. ACS Applied Materials & Interfaces. 9(5). 4457–4466. 53 indexed citations
16.
Sun, Minjie, Kaikai Wang, & David Oupický. (2017). Advances in Stimulus‐Responsive Polymeric Materials for Systemic Delivery of Nucleic Acids. Advanced Healthcare Materials. 7(4). 48 indexed citations
17.
Wang, Yazhe, Ying Xie, Jing Li, et al.. (2017). Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. ACS Nano. 11(2). 2227–2238. 414 indexed citations breakdown →
18.
Peng, Zheng‐Hong, Ying Xie, Yan Wang, Jing Li, & David Oupický. (2017). Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA. Molecular Pharmaceutics. 14(5). 1395–1404. 13 indexed citations
19.
Wang, Yan, Sushil Kumar, Satyanarayana Rachagani, et al.. (2016). Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis. Biomaterials. 101. 108–120. 30 indexed citations
20.
Li, Jing & David Oupický. (2014). Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor. Biomaterials. 35(21). 5572–5579. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026